WO2001051642A3 - Proteines de modification d'adn - Google Patents

Proteines de modification d'adn Download PDF

Info

Publication number
WO2001051642A3
WO2001051642A3 PCT/US2001/000870 US0100870W WO0151642A3 WO 2001051642 A3 WO2001051642 A3 WO 2001051642A3 US 0100870 W US0100870 W US 0100870W WO 0151642 A3 WO0151642 A3 WO 0151642A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna modification
dnamp
modification proteins
provides
proteins
Prior art date
Application number
PCT/US2001/000870
Other languages
English (en)
Other versions
WO2001051642A2 (fr
Inventor
Y Tom Tang
Preeti Lal
Jennifer L Hillman
Henry Yue
Yalda Azimzai
Dyung Aina M Lu
Mariah R Baughn
Original Assignee
Incyte Genomics Inc
Y Tom Tang
Preeti Lal
Jennifer L Hillman
Henry Yue
Yalda Azimzai
Dyung Aina M Lu
Mariah R Baughn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Y Tom Tang, Preeti Lal, Jennifer L Hillman, Henry Yue, Yalda Azimzai, Dyung Aina M Lu, Mariah R Baughn filed Critical Incyte Genomics Inc
Priority to CA002406722A priority Critical patent/CA2406722A1/fr
Priority to EP01901980A priority patent/EP1246923A2/fr
Priority to AU2001227830A priority patent/AU2001227830A1/en
Priority to JP2001551216A priority patent/JP2004500817A/ja
Publication of WO2001051642A2 publication Critical patent/WO2001051642A2/fr
Publication of WO2001051642A3 publication Critical patent/WO2001051642A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des protéines humaines de modification d'ADN (DNAMP) et les polynucléotides qui les identifient et les codent. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement ou de prévention de troubles liés à l'expression de DNAMP.
PCT/US2001/000870 2000-01-13 2001-01-10 Proteines de modification d'adn WO2001051642A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002406722A CA2406722A1 (fr) 2000-01-13 2001-01-10 Proteines de modification d'adn
EP01901980A EP1246923A2 (fr) 2000-01-13 2001-01-10 Proteines de modification d'adn
AU2001227830A AU2001227830A1 (en) 2000-01-13 2001-01-10 Dna modification proteins
JP2001551216A JP2004500817A (ja) 2000-01-13 2001-01-10 Ｄｎａ調節タンパク質

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17617800P 2000-01-13 2000-01-13
US60/176,178 2000-01-13

Publications (2)

Publication Number Publication Date
WO2001051642A2 WO2001051642A2 (fr) 2001-07-19
WO2001051642A3 true WO2001051642A3 (fr) 2002-03-28

Family

ID=22643314

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/000870 WO2001051642A2 (fr) 2000-01-13 2001-01-10 Proteines de modification d'adn

Country Status (5)

Country Link
EP (1) EP1246923A2 (fr)
JP (1) JP2004500817A (fr)
AU (1) AU2001227830A1 (fr)
CA (1) CA2406722A1 (fr)
WO (1) WO2001051642A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293491A1 (fr) * 1986-12-03 1988-12-07 MITSUI TOATSU CHEMICALS, Inc. PROCEDE DE PRODUCTION D'ADN $g(b) POLYMERASE DE MAMMIFERE ET SOUCHE D'E. COLI AINSI PRODUITE
WO1996021026A1 (fr) * 1994-12-30 1996-07-11 The Johns Hopkins University Mutations de la polymerase delta dans des tumeurs colo-rectales accompagnees d'erreurs de replication

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293491A1 (fr) * 1986-12-03 1988-12-07 MITSUI TOATSU CHEMICALS, Inc. PROCEDE DE PRODUCTION D'ADN $g(b) POLYMERASE DE MAMMIFERE ET SOUCHE D'E. COLI AINSI PRODUITE
WO1996021026A1 (fr) * 1994-12-30 1996-07-11 The Johns Hopkins University Mutations de la polymerase delta dans des tumeurs colo-rectales accompagnees d'erreurs de replication

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 7 January 2000 (2000-01-07), GARCIA-DIAZ M. ET AL.: "DNA polymerase lambda, a novel eukaryotic DNA polymerase with a potential role in meiosis", XP002166721, retrieved from EBI Database accession no. AJ131890 *
SENGUPTA D N ET AL: "SEQUENCE OF HUMAN DNA POLYMERASE-BETA MESSENGER RNA OBTAINED THROUGH COMPLEMENTARY DNA CLONING", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 136, no. 1, 1986, pages 341 - 347, XP000993355, ISSN: 0006-291X *

Also Published As

Publication number Publication date
CA2406722A1 (fr) 2001-07-19
JP2004500817A (ja) 2004-01-15
EP1246923A2 (fr) 2002-10-09
AU2001227830A1 (en) 2001-07-24
WO2001051642A2 (fr) 2001-07-19

Similar Documents

Publication Publication Date Title
WO2001012662A3 (fr) Proteines associees a la membrane
WO2000034477A3 (fr) Proteines associees a des neurones
WO2000018922A8 (fr) Proteines humaines associees a des glucides
WO2000009709A3 (fr) Proteases et proteines associees
WO2000052151A3 (fr) Proteines de secretion humaines
WO2000014251A3 (fr) Transferases humaines
WO2000044900A3 (fr) Proteines liant des acides nucleiques
WO2001044448A3 (fr) Proteines d'oxydoreductase humaines
WO2001096546A3 (fr) Proteine-phosphatases
WO1999038981A3 (fr) Molecules de proteine kinase humaines
WO1999041373A3 (fr) Molecules humaines associees au transport
WO2002010363A3 (fr) Proteines phosphatases
WO2003054219A3 (fr) Proteines associees a des acides nucleiques
WO2000008155A3 (fr) Proteines associees a un recepteur humain
WO1999049037A3 (fr) Molecules apparentees a la proteine-phosphatase
WO2001083524A3 (fr) Proteines du metabolisme de l'arn
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2003038052A3 (fr) Proteines associees aux acides nucleiques
WO2000023466A3 (fr) Proteines humaines de fixation de l'arn
WO2002042330A3 (fr) Proteines associees a un cystosquelette
WO2003010329A3 (fr) Proteines associees a des acides nucleiques
WO2000071679A3 (fr) Proteines d'oxydoreductase
WO2000052161A3 (fr) Proteines associees aux leucocytes et au systeme sanguin
WO2003016549A3 (fr) Proteines associees a des acides nucleiques
WO2002099115A3 (fr) Proteines associees a des acides nucleiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10181071

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 551216

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2406722

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001901980

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001901980

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001901980

Country of ref document: EP